RYALTRIS

Peak

olopatadine hydrochloride and mometasone furoate

NDANASALSPRAY, METERED

Approved

Jan 2022

Lifecycle

Peak

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Apr 8, 2039

159 months away

Patent Expiry

Apr 8, 2039

Patent Records (5)

Patent #	Expiry	Type	Use Code
9937189	Sep 4, 2034	Product	—
10376526	Sep 4, 2034	Product	—
10517880	Sep 4, 2034	Product	U-3297
10548907	Sep 4, 2034		U-3297
10561672	Sep 4, 2034	Product	—

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers